WO1998042739A3 - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them Download PDF

Info

Publication number
WO1998042739A3
WO1998042739A3 PCT/US1998/005653 US9805653W WO9842739A3 WO 1998042739 A3 WO1998042739 A3 WO 1998042739A3 US 9805653 W US9805653 W US 9805653W WO 9842739 A3 WO9842739 A3 WO 9842739A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides encoding
secreted proteins
polynucleotides
proteins
secreted
Prior art date
Application number
PCT/US1998/005653
Other languages
French (fr)
Other versions
WO1998042739A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to JP54587498A priority Critical patent/JP2002503955A/en
Priority to AU65783/98A priority patent/AU6578398A/en
Priority to CA002283631A priority patent/CA2283631A1/en
Priority to EP98911944A priority patent/EP0970111A2/en
Publication of WO1998042739A2 publication Critical patent/WO1998042739A2/en
Publication of WO1998042739A3 publication Critical patent/WO1998042739A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Polynucleotides and the proteins encoded thereby are disclosed.
PCT/US1998/005653 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them WO1998042739A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP54587498A JP2002503955A (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them
AU65783/98A AU6578398A (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them
CA002283631A CA2283631A1 (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them
EP98911944A EP0970111A2 (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82216797A 1997-03-21 1997-03-21
US08/822,167 1997-03-21
US4446698A 1998-03-19 1998-03-19
US09/044,466 1998-03-19

Publications (2)

Publication Number Publication Date
WO1998042739A2 WO1998042739A2 (en) 1998-10-01
WO1998042739A3 true WO1998042739A3 (en) 1998-12-03

Family

ID=26721594

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/005653 WO1998042739A2 (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP0970111A2 (en)
JP (1) JP2002503955A (en)
AU (1) AU6578398A (en)
CA (1) CA2283631A1 (en)
WO (1) WO1998042739A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410708B1 (en) 1997-11-21 2002-06-25 Genentech, Inc. Nucleic acids encoding A-33 related antigen polypeptides
AU9395998A (en) * 1997-09-17 1999-04-05 Genentech Inc. Compositions and methods for the treatment of immune related diseases
CA2382409A1 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7198917B2 (en) 1997-11-21 2007-04-03 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
US7282565B2 (en) 1998-03-20 2007-10-16 Genentech, Inc. PRO362 polypeptides
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
EP1481990B1 (en) * 1997-11-21 2007-06-06 Genentech, Inc. A-33 related antigens and their pharmacological uses
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
AU2008201101B2 (en) * 1999-03-11 2011-01-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
AU2005202246B2 (en) * 1999-03-11 2007-12-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
EP1163337B1 (en) 1999-03-11 2011-03-02 Merck Serono SA Vascular adhesion molecules and modulation of their function
EP1206479A1 (en) * 1999-08-24 2002-05-22 Texas Biotechnology Corporation A polynucleotide encoding a human junctional adhesion protein (jam-2)
WO2002012285A2 (en) * 2000-08-10 2002-02-14 Board Of Regents, The University Of Texas System The tumor suppressor car-1
AU2002211477A1 (en) * 2000-10-05 2002-04-15 Case Western Reserve University Suppressor of human breast cancer cell growth
JP2010504955A (en) 2006-09-28 2010-02-18 メルク セローノ ソシエテ アノニム Bonding molecule adhesion molecule C (JAM-C) binding compound and method of use thereof
DK2280996T3 (en) 2008-05-06 2016-12-19 Genentech Inc Affinity matured CRIg VARIANTS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Database EMBL, entry HS074341, Accession number N35074, 19 January 1996 100% identity with Seq.ID:1 nt.1702-2170 reverse orientation *
Database EMBL, entry HS081268, Accession number N21081, 8 January 1996 96% identity with Seq.ID:1 nt.636-1097 *
Database EMBL, entry HS814281, Accession number N43814, 9 February 1996 97% identity with Seq.ID:1 nt.1338-1659 *
Database EMBL, entry HSAA99506, Accession number AA099506, 29 October 1996 98% identity with Seq.ID:1 nt.546-927 *
Database EMBL, entry MM23812, Accession number W34238, 16 May 1996 92% identity with Seq.ID:1 nt.1323-1740 *
Database EMBL, entry MM35910, Accession number W29359, 10 May 1996 85% identity with Seq.ID:1 nt.112-506 *

Also Published As

Publication number Publication date
WO1998042739A2 (en) 1998-10-01
JP2002503955A (en) 2002-02-05
CA2283631A1 (en) 1998-10-01
AU6578398A (en) 1998-10-20
EP0970111A2 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
WO1998007859A3 (en) Secreted proteins and polynucleotides encoding them
WO1998017687A3 (en) Secreted proteins and polynucleotides encoding them
WO1999057132A8 (en) Secreted proteins and polynucleotides encoding them
WO1997007198A3 (en) Dna sequences and secreted proteins encoded thereby
WO1998033916A3 (en) Secreted proteins and polynucleotides encoding them
WO1998042739A3 (en) Secreted proteins and polynucleotides encoding them
WO1998042741A3 (en) Secreted proteins and polynucleotides encoding them
WO1998004693A3 (en) Secreted proteins and polynucleotides encoding them
WO1998055614A3 (en) Secreted proteins and polynucleotides encoding them
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
WO1998040486A3 (en) Secreted proteins and polynucleotides encoding them
WO1998005776A3 (en) Secreted proteins and polynucleotides encoding them
WO1998027205A3 (en) Secreted proteins and polynucleotides encoding them
WO1999058642A3 (en) Secreted proteins and polynucleotides encoding them
WO1998046757A3 (en) Secreted proteins and polynucleotides encoding them
WO1998032853A3 (en) Secreted proteins and polynucleotides encoding them
WO1998037094A3 (en) Secreted proteins and polynucleotides encoding them
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
WO1998040404A3 (en) Secreted proteins and polynucleotides encoding them
WO1998056909A3 (en) Secreted proteins and polynucleotides encoding them
WO1998030589A3 (en) Secreted proteins and polynucleotides encoding them
WO1998041539A3 (en) Secreted proteins and polynucleotides encoding them
WO1998021332A3 (en) Secreted proteins and polynucleotides encoding them
WO1998030696A8 (en) Secreted proteins and polynucleotides encoding them
WO1998030582A3 (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2283631

Country of ref document: CA

Ref country code: CA

Ref document number: 2283631

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 545874

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998911944

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998911944

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998911944

Country of ref document: EP